Dr Robert C Gallo talks about the importance of yearly AIDS congresses. He also talks about the scientific community before and during the AIDS epidemic, and puts the disease outbreak into a sociological context.

David Klatzmann is a french immunologist who has been working in an AIDS group in France since 1981. He talks about the discoveries that CD4-antigens function as receptors for the HIV virus and explains the structure of this relationship in detail.

Mary Marovich, medical scientist at The Walter Reed Army Medical Center in Washington, talks about the difficulties and possibilities of eventually finding an AIDS vaccine solution.

Luc Montagnier talks about the complex virology of HIV which makes the AIDS vaccine development so difficult. He also talks about the economic and cultural advantages of using traditional medicine as a part of the ARV therapy in developing countries.

Anthony Fauci is interviewed about the progression from HIV to AIDS. He talks about HIV long-term survivors and different aspects of non-progression to AIDS. He also reflects on the future for antiretroviral drugs and HIV vaccines.

Flossie Wong-Staal is an American Molecular Biologist who has been influencial in the HIV/AIDS research since the start of the US AIDS epidemic. She is known as the first scientist to clone HIV. In this interview she talks about the work on HIV gene therapy.

José Esparza is a scientist who has been working many years at WHO and within UNAIDS. He has been known for his work on HIV vaccines. Here he talks about vaccine trials and the future development of vaccines for developing and developed countries.

Praphan Phanupak, co-founder of the Thai Red Cross AIDS Research Center (TRC-ARC) and Professor at the Chulalongkorn University Hospital, tells about his encounter with the first AIDS patient in Thailand, about the health resources in Thailand and about stigma.

Robin Weiss, a British Molecular Biologist and Professor of Viral Oncology at University College London, talks about the scientific contribution of small countries like Sweden, interdisciplinary collaborations in HIV research and HIV vaccines.

Geoffrey Schild, Virologist and Director of the National Institute for Biological Standards and Control (NIBSC), talks about the Swedish contributions to AIDS research and collaboration with funding agencies such as Nutek, and reflects on HIV vaccines.

Dr George Galasso is working on HIV vaccines at NIAID. Here he talks about the scientific challenges of HIV/AIDS and the chances of developing a vaccine. He believes that one of the main focuses in HIV/AIDS research still is to find treatment for opportunistic infections.

Dr Robert Gallo is interviewed in the laboratory about the HIV virus and his ongoing work. He also talks with his team and discusses the question of international collaboration with Lars Olof Kallings. He answers questions about HIV and AIDS, drugs and promiscuity.